Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Particulate antigen‐delivery systems are instrumental for therapeutic vaccination, aiming at improving the safety and efficacy of treatments by targeting specialized antigen‐presenting cells (APCs). However, the induction of potent adaptive immune responses, especially cellular immunity, remains a m...

Full description

Saved in:
Bibliographic Details
Published in:Advanced NanoBiomed Research (Online) 2022-04, Vol.2 (4), p.n/a
Main Authors: Geisshüsler, Silvana, Schineis, Philipp, Langer, Lara, Wäckerle-Men, Ying, Leroux, Jean-Christophe, Halin, Cornelia, Vogel-Kindgen, Sarah, Johansen, Pål, Gander, Bruno
Format: Article
Language:English
Subjects:
adjuvants
amphiphilic cyclodextrins
Antigen presentation
Antigen processing
Antigen-presenting cells
Antigens
Aqueous solutions
Bone cancer
Bone marrow
Cancer
Cancer vaccines
CD8 antigen
Cell activation
Cell culture
Cell proliferation
Cell-mediated immunity
Cellular structure
Costimulator
Cyclodextrin
Cyclodextrins
Cytotoxicity
Dendritic cells
Immune response (cell-mediated)
Immune system
Lymphocytes
Lymphocytes T
Macrophages
Major histocompatibility complex
Molecular weight
Nanoparticles
Ovalbumin
peptide delivery
Peptides
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Particulate antigen‐delivery systems are instrumental for therapeutic vaccination, aiming at improving the safety and efficacy of treatments by targeting specialized antigen‐presenting cells (APCs). However, the induction of potent adaptive immune responses, especially cellular immunity, remains a major challenge. Herein, a novel nanoparticulate antigen‐delivery system based on amphiphilic cyclodextrins (CDs) is developed as a platform for therapeutic cancer vaccination. Supramolecular nanosized CD structures are formed in aqueous media and loaded with peptide antigens. The nanoparticle's adjuvant capacity is tested in cell experiments with murine bone marrow‐derived dendritic cells (BMDCs) or macrophages and T cells. Peptide‐loaded nanoparticles cause upregulation of costimulatory molecules on BMDCs and facilitate activation and proliferation of antigen‐specific T‐lymphocytes in vitro. Correct processing for major histocompatibility complex (MHC) class‐I antigen presentation is demonstrated using a capped version of the ovalbumin‐derived peptide SIINFEKL (c‐SFL). After immunization of mice with peptide‐loaded CD nanoparticles, the frequencies of antigen‐specific and cytokine‐producing CD8+ T cells are increased. This work sheds light on the immune‐stimulating properties of amphiphilic CD nanoparticles and reveals their considerable potential as carriers for cancer vaccines. Cyclodextrins are derivatized with alkyl chains to render them amphiphilic and formed into nanoparticles using a nanoprecipitation technique. Model peptides are successfully loaded and the NPs efficiently taken up by cells. The nanovaccines lead to upregulation of maturation markers as well as activation and proliferation of T cells. When immunizing mice with the vaccine, an adaptive immune response is elicited.
ISSN:2699-9307
2699-9307
DOI:10.1002/anbr.202100082